CDH2 and melanoma: The anti-metastasis effects of fisetin (5–20 μM) were revealed in melanoma cells, occurring through downregulation of mesenchymal markers (vimentin, N-cadherin, snail, and fibronectin) and upregulation of epithelial markers (desmoglein and E-cadherin) [110].